US Records 5,182 Measles Cases, Highest Since 1991 Amid Declining Vaccine Uptake

In a sweeping update released on March 18, the Centers for Disease Control and Prevention (CDC) reported 5,182 confirmed cases of measles in the United States, the highest number recorded since 1991. The data, evaluated through the year to date, place the United States on the brink of a measles renaissance, a prospect that follows a wave of declining vaccination rates and a sharpened debate over how measles‑related deaths are tallied.

Rising outbreak surpasses historic threshold

The tally of 5,182 cases includes more than 4,900 outbreak‑associated infections, a surge that essentially doubles the 2,289 measles cases the CDC recorded last year. Children below five years old account for 18 % of the total, and children between five and 19 years represent 41 %. In aggregate, those 0‑17‑year‑olds make up roughly 59 % of every confirmed case, underscoring the outbreak’s impact on youth, a group historically protected by robust childhood immunization schedules.

Vaccination coverage wanes

In the kindergarten population, coverage slipped from 95.2 % during the 2019‑2020 school year to 92.4 % in the 2025‑2026 school year, according to CDC data. This decline, though modest in percentage terms, represents thousands of children who enter school without the MMR vaccine’s protection, thereby weakening herd immunity and accelerating disease spread. The CDC notes that the outbreak’s bulk of cases are directly tied to this gap in coverage, linking declining vaccination rates to the return of a once‑controlled, vaccine‑preventable pathogen.

Counting deaths sparks federal‑state debate

Among the fallout, four individuals have died in 2026 as recorded by the CDC, a figure that contrasts sharply with numbers reported by state health agencies. Pennsylvania—the state most affected by the outbreak—has documented six deaths and 1,487 cases as of November. Commonwealth officials classify deaths as “measles‑associated” when a person with confirmed measles dies within 30 days after symptom onset unless the death results from an unrelated event. In August, the Pennsylvania Department of Health reported two unvaccinated adults who succumbed to measles. The CDC initially included those deaths in its national tally but subsequently removed them after U.S. Health Secretary Robert F. Kennedy Jr., a noted vaccine skeptic, questioned whether the deaths should be counted as measles fatalities. The dispute illustrates a growing rift between federal and state definitions of measles mortality and raises questions about public‑health accountability and transparency.

Broader civic consequences

Beyond statistics, the outbreak places significant pressure on public‑health institutions and raises concerns about the legal frameworks that govern disease reporting. A narrower Definition of measles mortality at the state level allows Pennsylvania to allocate emergency resources, apply for federal matching funds, and pursue litigation against parties that it believes hinder vaccination efforts. In contrast, the CDC’s more restrictive criteria, shaped by federal guidelines, influence national policy decisions, funding allocations, and public trust in disease surveillance. The dispute also underscores the need for unified protocols for classifying deaths, which in turn affect transparency regarding the true public‑health burden of measles. Communities, especially those with younger populations and lower vaccination rates, bear the bulk of the outbreak’s toll. This situation invites scrutiny of how health data are communicated to the public, how voting on vaccination mandates reflects civic values, and how court‑ordered interventions might safeguard the most vulnerable demographics. As the United States grapples with a 35‑year high in measles cases, civic stakeholders, policymakers, and the public must navigate a complex nexus of institutional accountability, democratic governance of public health, and the protection of child health in an era of vaccine hesitancy.